Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Surgical Wound Infection 5Neoplasms 4Colorectal Neoplasms 4Sepsis 2Rectal Neoplasms 2Pancreatic Neoplasms 2Leukemia, Myeloid, Acute 2Febrile Neutropenia 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solitary Pulmonary Nodule 1Skin Neoplasms 1Pancreatic Fistula 1Neutropenia 1Neoplasms, Plasma Cell 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Intestinal Neoplasms 1Inflammation 1Infections 1Hematologic Neoplasms 1Glioblastoma 1Fever 1Exanthema 1Emergencies 1

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Anti-Bacterial Agents × Clear all
NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
114 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡